157 results on '"Agar, Meera"'
Search Results
2. Experience and acceptability of a carer‐focussed intervention in acute oncology settings: A qualitative study of people with advanced cancer and their carers.
- Author
-
Marston, Celia, Morgan, Deidre D., Philip, Jennifer, and Agar, Meera R.
- Subjects
CAREGIVER attitudes ,SERVICES for caregivers ,OCCUPATIONAL therapy needs assessment ,SPECIALTY hospitals ,RESEARCH methodology ,MELANOMA ,TRANSITIONAL care ,INTERVIEWING ,GLIOMAS ,PATIENTS' attitudes ,EXPERIENCE ,OCCUPATIONAL therapy ,CANCER patients ,CANCER treatment ,QUALITATIVE research ,SELF-consciousness (Awareness) ,CRITICAL care medicine ,FIELD notes (Science) ,RESEARCH funding ,NEEDS assessment ,THEMATIC analysis ,DATA analysis software ,CANCER patient medical care ,DISCHARGE planning - Abstract
Objectives: Providing optimal support for carers of people with advanced cancer is critical to facilitating discharge home from hospital. Carer Support Needs Assessment Tool–Intervention (CSNAT‐I) has shown promise in supporting carers' needs in this context. This study aimed to explore patient and carers experiences with and views on the acceptability of the CSNAT‐I delivered by occupational therapists in an acute oncology setting. Methods: People with advanced cancer and their carers who had previously received the CSNAT‐I as part of usual care while admitted to an Australian specialist cancer centre or acute hospital were invited to participate in interviews exploring their perceptions of the intervention. Data were analysed thematically. Results: Two patients and 10 carers participated in semi‐structured interviews. Three themes were constructed from the data: Carers viewed the CSNAT‐I as comprehensive process that (1) 'covered everything' related to discharge planning; (2) generated an 'increased awareness of needs' for themselves, patients, and clinicians; and (3) triggered an emotional response of feeling 'wrapped up in care' that was maintained as they moved from hospital to home. Conclusion: This study has demonstrated that the CSNAT‐I was highly acceptable to carers as part of existing discharge processes supporting them through the transition from hospital to home and can be delivered by occupational therapists and other clinicians with a natural synergy to discharge planning. These findings will inform further development and testing of the delivery model of the CSNAT‐I in future trials. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Role of palliative care in survivorship
- Author
-
Agar, Meera, Luckett, Tim, and Phillips, Jane
- Published
- 2015
4. Perceptions of Australian Palliative Medicine Specialists Toward Acupuncture for Palliative Care.
- Author
-
Chan, Olivea, Agar, Meera, and Zhu, Xiaoshu
- Subjects
- *
TUMOR treatment , *THERAPEUTICS , *WORK environment , *CANCER patient psychology , *CONFIDENCE , *PROFESSIONS , *DISCUSSION , *ATTITUDE (Psychology) , *ACUPUNCTURE , *PHYSICIAN-patient relations , *PHYSICIANS' attitudes , *MEDICAL care costs , *UNCERTAINTY , *PALLIATIVE medicine , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *MEDICAL referrals , *INTEGRATED health care delivery , *PSYCHOLOGY of physicians , *PALLIATIVE treatment - Abstract
Background: With increasing multidisciplinary care strategies, palliative medicine practitioner perceptions toward acupuncture integration are significant. Objective: To evaluate acupuncture availability and acceptability in Australian palliative care. Outcomes: (1) Domains of the survey included participant characteristics, (2) workplace availability, (3) personal attitudes, and (4) recommendation likelihood. Design: An online REDCap survey of Australian palliative medicine practitioners was administered. Results: Acupuncture was mostly not available/permitted at workplaces (45.2%) due to cost/funding (57.1%) and limited evidence (57.1%). When available by workplace (24.2%) or affiliated service (4.8%), doctors mostly administered acupuncture (66.7%). Respondents were not up to date with current research (71.4%). Referral likelihood increased with confidence in provider (80.0%), workplace availability (77.1%), and patient prior/current use (77.1%). Patient acupuncture discussions were rare (62.9%) with barriers of effectiveness uncertainty (71.4%) and limited knowledge of availability (57.1%). Conclusion: Despite available integrative services and acceptability by Australian palliative medicine practitioners, utilization is low. Further research into acupuncture effectiveness for palliative symptoms, feasibility, and patient acceptability is required. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Cancer survivors' exercise beliefs, knowledge, and behaviors: An Australian National Survey.
- Author
-
Caperchione, Cristina M., Stolp, Sean, Phillips, Jane L., Agar, Meera, Sharp, Paul, Liauw, Winston, Harris, Carole A., McCullough, Susan, and Lilian, Ruth
- Subjects
CANCER survivors ,PHYSICAL activity ,ONE-way analysis of variance ,CANCER patients ,CANCER treatment ,HOSPITAL surveys - Abstract
Aims: This study aimed to (1) explore the perceptions of people living with cancer about exercise in general and exercise as an adjunct form of cancer care, (2) explore their perceptions regarding exercise counselling needs and preferences, and (3) investigate how these perceptions of exercise as an adjunct form of cancer care shape survivors exercise levels postcancer diagnosis. Methods: A cross‐sectional design and online survey were used to recruit cancer survivors via cancer‐related networks throughout Australia. Two factor analyses were conducted to examine the structure and reduce the number of variables pertaining to exercise during and after the cancer treatment. Extracted components were used in one‐way analysis of variance to compare differences in physical activity levels postcancer diagnosis. Results: Participants (N = 288) had very positive perceptions of exercise, yet only 50% of participants would prefer to receive exercise counselling. Those who were more active postcancer diagnosis had higher exercise beliefs than those who were similarly active (p = 0.04, r = 0.27) and less active (p = 0.03, r = 0.24) postdiagnosis. Those who were less active also had lower exercise knowledge than those who were similarly active (p = 0.01, r = 0.31) and more active (p = 0.03, r = 0.26). Safety beliefs did not significantly differ between cancer survivors' activity levels (p = 0.16) Conclusion: This survey highlights the potential benefits of a concentrated effort in connecting survivors to relevant services and resources, and utilizing cancer clinicians to communicate with survivors about the role of exercise in cancer care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Caring for depression in the dying is complex and challenging – survey of palliative physicians.
- Author
-
Lee, Wei, Chang, Sungwon, DiGiacomo, Michelle, Draper, Brian, Agar, Meera R., and Currow, David C.
- Subjects
DIAGNOSIS of mental depression ,TERMINAL care ,CROSS-sectional method ,PHYSICIANS' attitudes ,MEDICAL screening ,UNCERTAINTY ,MENTAL depression ,QUESTIONNAIRES ,INTERPROFESSIONAL relations ,DESCRIPTIVE statistics ,PHYSICIANS ,PALLIATIVE treatment ,LONGITUDINAL method - Abstract
Background: Depression is prevalent in people with very poor prognoses (days to weeks). Clinical practices and perceptions of palliative physicians towards depression care have not been characterised in this setting. The objective of this study was to characterise current palliative clinicians' reported practices and perceptions in depression screening, assessment and management in the very poor prognosis setting. Methods: In this cross-sectional cohort study, 72 palliative physicians and 32 psychiatrists were recruited from Australian and New Zealand Society of Palliative Medicine and Royal Australian and New Zealand College of Psychiatrists between February and July 2020 using a 23-item anonymous online survey. Results: Only palliative physicians results were reported due to poor psychiatry representation. Palliative physicians perceived depression care in this setting to be complex and challenging. 40.0% reported screening for depression. All experienced uncertainty when assessing depression aetiology. Approaches to somatic symptom assessment varied. Physicians were generally less likely to intervene for depression than in the better prognosis setting. Most reported barriers to care included the perceived lack of rapidly effective therapeutic options (77.3%), concerns of patient burden and intolerance (71.2%), and the complexity in diagnostic differentiation (53.0%). 66.7% desired better collaboration between palliative care and psychiatry. Conclusions: Palliative physicians perceived depression care in patients with very poor prognoses to be complex and challenging. The lack of screening, variations in assessment approaches, and the reduced likelihood of intervening in comparison to the better prognosis setting necessitate better collaboration between palliative care and psychiatry in service delivery, training and research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
- Author
-
Ekström, Magnus, Ferreira, Diana, Chang, Sungwon, Louw, Sandra, Johnson, Miriam J., Eckert, Danny J., Fazekas, Belinda, Clark, Katherine J., Agar, Meera R., Currow, David C., and Australian National Palliative Care Clinical Studies Collaborative
- Subjects
CHRONIC obstructive pulmonary disease ,PEDOMETERS ,DYSPNEA ,MORPHINE ,CLINICAL trials ,CONTROLLED release drugs ,EVALUATION research ,BLIND experiment ,RANDOMIZED controlled trials ,OBSTRUCTIVE lung diseases ,RESEARCH ,COMPARATIVE studies ,DISEASE complications - Abstract
Importance: Chronic breathlessness is common in people with chronic obstructive pulmonary disease (COPD). Regular, low-dose, extended-release morphine may relieve breathlessness, but evidence about its efficacy and dosing is needed.Objective: To determine the effect of different doses of extended-release morphine on worst breathlessness in people with COPD after 1 week of treatment.Design, Setting, and Participants: Multicenter, double-blind, placebo-controlled randomized clinical trial including people with COPD and chronic breathlessness (defined as a modified Medical Research Council score of 3 to 4) conducted at 20 centers in Australia. People were enrolled between September 1, 2016, and November 20, 2019, and followed up through December 26, 2019.Interventions: People were randomized 1:1:1 to 8 mg/d or 16 mg/d of oral extended-release morphine or placebo during week 1. At the start of weeks 2 and 3, people were randomized 1:1 to 8 mg/d of extended-release morphine, which was added to the prior week's dose, or placebo.Main Outcomes and Measures: The primary outcome was change in the intensity of worst breathlessness on a numerical rating scale (score range, 0 [none] to 10 [being worst or most intense]) using the mean score at baseline (from days -3 to -1) to the mean score after week 1 of treatment (from days 5 to 7) in the 8 mg/d and 16 mg/d of extended-release morphine groups vs the placebo group. Secondary outcomes included change in daily step count measured using an actigraphy device from baseline (day -1) to the mean step count from week 3 (from days 19 to 21).Results: Among the 160 people randomized, 156 were included in the primary analyses (median age, 72 years [IQR, 67 to 78 years]; 48% were women) and 138 (88%) completed treatment at week 1 (48 in the 8 mg/d of morphine group, 43 in the 16 mg/d of morphine group, and 47 in the placebo group). The change in the intensity of worst breathlessness at week 1 was not significantly different between the 8 mg/d of morphine group and the placebo group (mean difference, -0.3 [95% CI, -0.9 to 0.4]) or between the 16 mg/d of morphine group and the placebo group (mean difference, -0.3 [95%, CI, -1.0 to 0.4]). At week 3, the secondary outcome of change in mean daily step count was not significantly different between the 8 mg/d of morphine group and the placebo group (mean difference, -1453 [95% CI, -3310 to 405]), between the 16 mg/d of morphine group and the placebo group (mean difference, -1312 [95% CI, -3220 to 596]), between the 24 mg/d of morphine group and the placebo group (mean difference, -692 [95% CI, -2553 to 1170]), or between the 32 mg/d of morphine group and the placebo group (mean difference, -1924 [95% CI, -47 699 to 921]).Conclusions and Relevance: Among people with COPD and severe chronic breathlessness, daily low-dose, extended-release morphine did not significantly reduce the intensity of worst breathlessness after 1 week of treatment. These findings do not support the use of these doses of extended-release morphine to relieve breathlessness.Trial Registration: ClinicalTrials.gov Identifier: NCT02720822. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Stakeholder perspectives of a pilot multicomponent delirium prevention intervention for adult patients with advanced cancer in palliative care units: A behaviour change theory-based qualitative study.
- Author
-
Green, Anna, Hosie, Annmarie, Phillips, Jane L, Kochovska, Slavica, Noble, Beverly, Brassil, Meg, Cumming, Anne, Lawlor, Peter G, Bush, Shirley H, Davis, Jan Maree, Edwards, Layla, Hunt, Jane, Wilcock, Julie, Phillipson, Carl, Wesley Ely, Eugene, Parr, Cynthia, Lovell, Melanie, and Agar, Meera
- Subjects
CANCER patient psychology ,PILOT projects ,OCCUPATIONAL roles ,PROFESSIONS ,ATTITUDES of medical personnel ,RESEARCH methodology ,MOTIVATION (Psychology) ,HOSPITAL health promotion programs ,INTERVIEWING ,HUMAN services programs ,PATIENTS' attitudes ,FAMILY attitudes ,QUALITATIVE research ,CONCEPTUAL structures ,DOCUMENTATION ,HOSPITAL wards ,DELIRIUM ,INTERPROFESSIONAL relations ,CONTENT analysis ,THEMATIC analysis ,PATIENT compliance ,PALLIATIVE treatment ,BEHAVIOR modification ,CORPORATE culture - Abstract
Background: Theory-based and qualitative evaluations in pilot trials of complex clinical interventions help to understand quantitative results, as well as inform the feasibility and design of subsequent effectiveness and implementation trials. Aim: To explore patient, family, clinician and volunteer ('stakeholder') perspectives of the feasibility and acceptability of a multicomponent non-pharmacological delirium prevention intervention for adult patients with advanced cancer in four Australian palliative care units that participated in a phase II trial, the 'PRESERVE pilot study'. Design: A trial-embedded qualitative study via semi-structured interviews and directed content analysis using Michie's Behaviour Change Wheel and the Theoretical Domains Framework. Setting/participants: Thirty-nine people involved in the trial: nurses (n = 17), physicians (n = 6), patients (n = 6), family caregivers (n = 4), physiotherapists (n = 3), a social worker, a pastoral care worker and a volunteer. Results: Participants' perspectives aligned with the 'capability', 'opportunity' and 'motivation' domains of the applied frameworks. Of seven themes, three were around the alignment of the delirium prevention intervention with palliative care (intervention was considered routine care; intervention aligned with the compassionate and collaborative culture of palliative care; and differing views of palliative care priorities influenced perspectives of the intervention) and four were about study processes more directly related to adherence to the intervention (shared knowledge increased engagement with the intervention; impact of the intervention checklist on attention, delivery and documentation of the delirium prevention strategies; clinical roles and responsibilities; and addressing environmental barriers to delirium prevention). Conclusion: This theory-informed qualitative study identified multiple influences on the delivery and documentation of a pilot multicomponent non-pharmacological delirium prevention intervention in four palliative care units. Findings inform future definitive studies of delirium prevention in palliative care. Australian New Zealand Clinical Trials Registry, ACTRN12617001070325; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373168 [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Analysis of discharge documentation for older adults living with dementia: A cohort study.
- Author
-
Parker, Kirsten J., Phillips, Jane L., Luckett, Tim, Agar, Meera, Ferguson, Caleb, and Hickman, Louise D.
- Subjects
MEDICAL quality control ,HOSPITALS ,AUDITING ,FUNCTIONAL status ,MILD cognitive impairment ,MEDICAL care ,HEALTH status indicators ,COGNITION ,MENTAL health ,DOCUMENTATION ,DEMENTIA patients ,NURSING care facilities ,SOCIOECONOMIC factors ,CONTINUUM of care ,DESCRIPTIVE statistics ,KARNOFSKY Performance Status ,CHI-squared test ,NEEDS assessment ,DATA analysis software ,DISCHARGE planning ,LONGITUDINAL method ,SECONDARY analysis - Abstract
Background: Older adults living with dementia frequently transition between healthcare settings. Care transitions increase vulnerability and risk of iatrogenic harm. Aim and objective: To examine the quality of transitional care arrangements within discharge documentation for older people living with dementia. Design: Secondary analysis of cohort study data. Method: A secondary analysis of the IDEAL Study [ACTRN12612001164886] discharge documents, following the STROBE guidelines. Participants had a confirmed diagnosis of dementia and were discharged from hospital to a nursing home. An audit tool was used to extract the data. This was developed through a synthesis of existing tools and finalised by an expert panel. The analysis assessed the quality of discharge documentation, in the context of transitional care needs, and presented results using descriptive statistics. Functional ability; physical health; cognition and mental health; medications; and socio environmental factors were assessed. Results: Sixty participants were included in analyses, and half were male (52%), with a total participant mean age of 83 (SD 8.7) years. There was wide variability in the quality of core discharge information, ranging from excellent (37%), adequate (43%) to poor (20%). A sub‐group of these core discharge documentation elements that detailed the participants transitional care needs were rated as follows: excellent (17%), adequate (46%) and poor (37%). Conclusion: Discharge documentation fails to meet needs of people living with dementia. Improving the quality of discharge documentation for people living with dementia transitioning from hospital to nursing home is critical to provide safe and quality care. Relevance to clinical practice: There is a need for safe, timely, accurate and comprehensive discharge information to ensure the safety of people living with dementia and prevent adverse harm. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Clinicians' delirium treatment practice, practice change, and influences: A national online survey.
- Author
-
Hosie, Annmarie, Agar, Meera, Caplan, Gideon A, Draper, Brian, Hedger, Stephen, Rowett, Debra, Tuffin, Penny, Cheah, Seong Leang, Phillips, Jane L, Brown, Linda, Sidhu, Manraaj, and Currow, David C
- Subjects
- *
PROFESSIONAL practice , *CONFIDENCE intervals , *CONCEPTUAL structures , *SURVEYS , *BENZODIAZEPINES , *DELIRIUM , *HEALTH behavior , *DESCRIPTIVE statistics , *EMOTIONS , *ODDS ratio , *PALLIATIVE treatment , *BEHAVIOR modification , *ANTIPSYCHOTIC agents , *PSYCHOLOGICAL distress , *OFF-label use (Drugs) , *TRANQUILIZING drugs - Abstract
Background: Recent studies cast doubt on the net effect of antipsychotics for delirium. Aim: To investigate the influence of these studies and other factors on clinicians' delirium treatment practice and practice change in palliative care and other specialties using the Theoretical Domains Framework. Design: Australia-wide online survey of relevant clinicians. Setting/participants: Registered nurses (72%), doctors (16%), nurse practitioners (6%) and pharmacists (5%) who cared for patients with delirium in diverse settings, recruited through health professionals' organisations. Results: Most of the sample (n = 475): worked in geriatrics/aged (31%) or palliative care (30%); in hospitals (64%); and saw a new patient with delirium at least weekly (61%). More (59%) reported delirium practice change since 2016, mostly by increased non-pharmacological interventions (53%). Fifty-five percent reported current antipsychotic use for delirium, primarily for patient distress (79%) and unsafe behaviour (67%). Common Theoretical Domains Framework categories of influences on respondents' delirium practice were: emotion (54%); knowledge (53%) and physical (43%) and social (21%) opportunities. Palliative care respondents more often reported: awareness of any named key study of antipsychotics for delirium (73% vs 39%, p < 0.001); changed delirium treatment (73% vs 53%, p = 0.017); decreased pharmacological interventions (60% vs 15%, p < 0.001); off-label medication use (86% vs 51%, p < 0.001: antipsychotics 79% vs 44%, p < 0.001; benzodiazepines 61% vs 26%, p < 0.001) and emotion as an influence (82% vs 39%, p < 0.001). Conclusion: Clinicians' use of antipsychotic during delirium remains common and is primarily motivated by distress and safety concerns for the patient and others nearby. Supporting clinicians to achieve evidence-based delirium practice requires further work. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Cost comparison of different models of palliative care delivery.
- Author
-
Comans, Tracy, Nguyen, Kim‐Huong, Stafford‐Bell, Fiona, and Agar, Meera
- Subjects
RESEARCH methodology ,COST control ,COMPARATIVE studies ,COST analysis ,RESIDENTIAL care ,HOSPITAL wards ,STATISTICAL models ,PALLIATIVE treatment ,ELDER care ,MEDICAL needs assessment ,OLD age - Abstract
Objective: The aim of this project was to assess the value for money of a modified unit within a residential aged care facility (RACF) for people requiring palliative care at the end of life. Methods: A three‐way comparison using a mixed‐method costing was used to estimate the per day cost of the unit compared to care in a palliative care unit within a hospital and a standard RACF bed. Results: The cost of the unit was estimated at $242 per day (2015 Australian dollars). The palliative care hospital bed cost $1,664 per day. The cost of a standard RACF bed was $123 per day, indicating that an additional $120 per day is required to provide the higher level of care required by people with complex palliative care needs. Conclusion: A modified RACF unit could provide substantial cost savings to the health budget for selected complex palliative care patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Australian long-term care personnel's knowledge and attitudes regarding palliative care for people with advanced dementia.
- Author
-
Luckett, Tim, Luscombe, Georgina, Phillips, Jane, Beattie, Elizabeth, Chenoweth, Lynnette, Davidson, Patricia M, Goodall, Stephen, Pond, Dimity, Mitchell, Geoffrey, and Agar, Meera
- Subjects
STATISTICS ,WORK experience (Employment) ,MEDICAL quality control ,PROFESSIONS ,ATTITUDE (Psychology) ,MULTIVARIATE analysis ,MEDICAL personnel ,DEMENTIA patients ,NURSES ,QUESTIONNAIRES ,PALLIATIVE treatment ,EDUCATIONAL attainment - Abstract
This study aimed to describe Australian long-term care (LTC) personnel's knowledge and attitudes concerning palliative care for residents with advanced dementia, and explore relationships with LTC facility/personnel characteristics. An analysis was undertaken of baseline data from a cluster randomised controlled trial of facilitated family case conferencing for improving palliative care of LTC residents with advanced dementia (the 'IDEAL Study'). Participants included any LTC personnel directly involved in residents' care. Knowledge and attitudes concerning palliative care for people with advanced dementia were measured using the questionnaire on Palliative Care for Advanced Dementia. Univariate and multivariate analyses explored relationships between personnel knowledge/attitudes and facility/personnel characteristics. Of 307 personnel in the IDEAL Study, 290 (94.5%) from 19/20 LTCFs provided sufficient data for inclusion. Participants included 9 (2.8%) nurse managers, 59 (20.5%) registered nurses, 25 (8.7%) enrolled nurses, 187 (64.9%) assistants in nursing/personal care assistants and 9 (3.1%) care service employees. In multivariate analyses, a facility policy not to rotate personnel through dementia units was the only variable associated with more favourable overall personnel knowledge and attitudes. Other variables associated with favourable knowledge were a designation of nursing manager or registered or enrolled nurse, and having a preferred language of English. Other variables associated with favourable attitudes were tertiary level of education and greater experience in dementia care. Like previous international research, this study found Australian LTC personnel knowledge and attitudes regarding palliative care for people with advanced dementia to be associated with both facility and personnel characteristics. Future longitudinal research is needed to better understand the relationships between knowledge and attitudes, as well as between these attributes and quality of care. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Quality of online self-management resources for adults living with primary brain cancer, and their carers: a systematic environmental scan.
- Author
-
Schaefer, Isabelle, Heneka, Nicole, Luckett, Tim, Agar, Meera R., Chambers, Suzanne K., Currow, David C., Halkett, Georgia, Disalvo, Domenica, Amgarth-Duff, Ingrid, Anderiesz, Cleola, and Phillips, Jane L.
- Subjects
BRAIN tumor treatment ,CANCER patients ,CAREGIVERS ,CONTINUUM of care ,INTERNET ,MEDICINE information services ,SELF-management (Psychology) ,SYSTEMATIC reviews ,ACCESS to information ,HEALTH literacy ,HEALTH information services ,DESCRIPTIVE statistics ,ADULTS - Abstract
Background: A primary brain cancer diagnosis is a distressing, life changing event. It adversely affects the quality of life for the person living with brain cancer and their families ('carers'). Timely access to evidence-based information is critical to enabling people living with brain cancer, and their carers, to self-manage the devastating impacts of this disease. Method: A systematic environmental scan of web-based resources. A depersonalised search for online English-language resources published from 2009 to December 2019 and designed for adults (> 25 years of age), living with primary brain cancer, was undertaken using the Google search engine. The online information was classified according to: 1) the step on the cancer care continuum; 2) self-management domains (PRISMS taxonomy); 3) basic information disclosure (Silberg criteria); 4) independent quality verification (HonCode); 5) reliability of disease and treatment information (DISCERN Sections 1 and 2); and readability (Flesch-Kincaid reading grade). Results: A total of 119 online resources were identified, most originating in England (n = 49); Australia (n = 27); or the USA (n = 27). The majority of resources related to active treatment (n = 76), without addressing recurrence (n = 3), survivorship (n = 1) or palliative care needs (n = 13). Few online resources directly provided self-management advice for adults living with brain cancer or their carers. Just over a fifth (n = 26, 22%) were underpinned by verifiable evidence. Only one quarter of organisations producing resources were HonCode certified (n = 9, 24%). The median resource reliability as measured by Section 1, DISCERN tool, was 56%. A median of 8.8 years of education was required to understand these online resources. Conclusions: More targeted online information is needed to provide people affected by brain cancer with practical self-management advice. Resources need to better address patient and carer needs related to: rehabilitation, managing behavioural changes, survivorship and living with uncertainty; recurrence; and transition to palliative care. Developing online resources that don't require a high level of literacy and/or cognition are also required. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Professionals' views and experiences in supporting decision-making involvement for people living with dementia.
- Author
-
Sinclair, Craig, Bajic-Smith, Julie, Gresham, Meredith, Blake, Meredith, Bucks, Romola S, Field, Sue, Clayton, Josephine M, Radoslovich, Helen, Agar, Meera, and Kurrle, Susan
- Subjects
OCCUPATIONAL roles ,MEDICAL databases ,INFORMATION storage & retrieval systems ,GROUNDED theory ,RESEARCH methodology ,MEDICAL personnel ,INTERVIEWING ,DECISION support systems ,DEMENTIA patients ,QUALITATIVE research ,CONCEPTUAL structures ,PSYCHOSOCIAL factors ,DECISION making in clinical medicine - Abstract
Background: The provision of supported decision-making for people living with disabilities is an emerging area of practice and rights-based law reform, and is required under international law. Objectives: This qualitative study aimed to understand how Australian health and legal professionals conceptualised their professional roles in the practice of providing decision-making support for people living with dementia. Methods: The methods were informed by grounded theory principles. In-depth, semi-structured interviews were conducted with 28 health and legal professionals involved in providing care or services for people with dementia. Interviews explored how professionals described their practice of providing support for decision-making and how they conceptualised their roles. The analysis was underpinned by the theoretical perspective of symbolic interactionism. Results: Participants described providing support across a range of decision domains, some of which were specific to their professional role. Four key themes were identified: 'establishing a basis for decision-making', 'the supportive toolbox', 'managing professional boundaries' and 'individualist advocacy versus relational practice'. Participants identified a range of generic and specialised techniques they used to provide support for people with dementia. These techniques were applied subject to resource limitations and perceived professional obligations and boundaries. A continuum of professional practice, ranging from 'individualist advocacy' to 'relational practice' describes the approaches adopted by different professionals. Discussion: Professionals conceptualised their role in providing support for decision-making through the lens of their own profession. Differences in positioning on the continuum of 'individualist advocacy' through to 'relational practice' had practical implications for capacity assessment, engaging with persons with impaired decision-making capacity, and the inclusion of supporters and family members in decision-making processes. Further progress in implementing supported decision-making (including through law and policy reform) will require an understanding of these inter-professional differences in perceived roles relating to the practice of providing decision-making support. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Financial stress experienced by informal carers of adults with a chronic disease: Results from an Australian population‐based cross‐sectional survey.
- Author
-
DiGiacomo, Michelle, Chang, Sungwon, Luckett, Tim, Agar, Meera, Phillips, Jane, and Lam, Lawrence
- Subjects
PSYCHOLOGY of caregivers ,CHRONIC diseases ,CONFIDENCE intervals ,MENTAL illness ,PSYCHOLOGICAL stress ,SOCIOECONOMIC factors ,CROSS-sectional method ,DESCRIPTIVE statistics ,ODDS ratio - Abstract
Objective: To identify caregiving characteristics that are associated with financial stress in Australian carers of people with a chronic disease. Methods: Data were collected via the South Australian Health Omnibus, an annual population‐based, cross‐sectional survey. Individuals who provided care to someone with prevalent chronic conditions were asked about financial stress and caregiving characteristics. Results: Of 32.4% (988/3047) who were carers, 13.4% (132/988) experienced financial stress. Adjusting for age and household income, providing more than 20 hours of care per week (AOR = 2.39, 95% CI = 1.48‐3.86), transport assistance (AOR = 1.89, 95% CI = 1.15‐3.09) and assistance with household tasks (AOR = 1.92, 95% CI = 1.14‐3.26) and caring for a person with a mental illness (AOR = 2.01, 95% CI = 1.24‐3.28) were associated with a significant increase in odds of experiencing financial stress. Caring for a person with cancer (AOR = 0.49, 95% CI = 0.30‐0.81) or dementia (AOR = 0.40, 95% CI = 0.21‐0.76) was associated with decrease in odds. Conclusions: Financial stress was reported by more than 13% of carers, and factors other than household income were implicated. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Symptomatic Events in a Community Palliative Care Population: A Prospective Pilot Study.
- Author
-
To, Timothy H.M., Collier, Aileen, Agar, Meera R., Rowett, Debra, and Currow, David C.
- Subjects
COMMUNITY health services ,LONGITUDINAL method ,PALLIATIVE treatment ,STATISTICAL sampling ,TERMINALLY ill ,PILOT projects ,DISEASE prevalence ,PATIENTS' attitudes ,ADVERSE health care events - Abstract
Background: The palliative care population is prescribed a large number of drugs, increasing as patients deteriorate. The cumulative effects of these medications combined with underlying symptom burden can result in significant morbidity. There is an urgent need to describe possible symptomatic events that could be exacerbated by commonly prescribed drugs in palliative care and their impact. Objectives: To trial the feasibility and acceptability of determining baseline symptomatic event rates for community palliative care patients from which a composite measure of symptomatic events can be developed. Design: This prospective pilot study of patient-reported symptomatic events recruited a convenience cohort of 27 community palliative care patients in a metropolitan specialist palliative care service in Australia. Results: This study has demonstrated a high prevalence rate of symptomatic events (total crude event/participant day rate 0.87) in the study population. Conclusion: Data collection of patient-centered symptomatic events was acceptable and feasible to participants. This pilot supports a fully powered study. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
- Author
-
Weinkove, Robert, McQuilten, Zoe K, Adler, Jonathan, Agar, Meera R, Blyth, Emily, Cheng, Allen C, Conyers, Rachel, Haeusler, Gabrielle M, Hardie, Claire, Jackson, Christopher, Lane, Steven W, Middlemiss, Tom, Mollee, Peter, Mulligan, Stephen P, Ritchie, David, Ruka, Myra, Solomon, Benjamin, Szer, Jeffrey, Thursky, Karin A, and Wood, Erica M
- Subjects
COVID-19 pandemic ,PEDIATRIC hematology ,MEDICAL care ,COVID-19 ,SOCIAL distancing ,BONE marrow transplantation - Abstract
Introduction: A pandemic coronavirus, SARS-CoV-2, causes COVID-19, a potentially life-threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID-19. Community transmission of COVID-19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic.Main Recommendations: During the COVID-19 pandemic: In patients with cancer with fever and/or respiratory symptoms, consider causes in addition to COVID-19, including other infections and therapy-related pneumonitis. For suspected or confirmed COVID-19, discuss temporary cessation of cancer therapy with a relevant specialist. Provide information on COVID-19 for patients and carers. Adopt measures within cancer centres to reduce risk of nosocomial SARS-CoV-2 acquisition; support population-wide social distancing; reduce demand on acute services; ensure adequate staffing; and provide culturally safe care. Measures should be equitable, transparent and proportionate to the COVID-19 threat. Consider the risks and benefits of modifying cancer therapies due to COVID-19. Communicate treatment modifications, and review once health service capacity allows. Consider potential impacts of COVID-19 on the blood supply and availability of stem cell donors. Discuss and document goals of care, and involve palliative care services in contingency planning.Changes in Management AsA Result Of This Statement: This interim consensus guidance provides a framework for clinicians managing patients with cancer during the COVID-19 pandemic. In view of the rapidly changing situation, clinicians must also monitor national, state, local and institutional policies, which will take precedence.Endorsed By: Australasian Leukaemia and Lymphoma Group; Australasian Lung Cancer Trials Group; Australian and New Zealand Children's Haematology/Oncology Group; Australia and New Zealand Society of Palliative Medicine; Australasian Society for Infectious Diseases; Bone Marrow Transplantation Society of Australia and New Zealand; Cancer Council Australia; Cancer Nurses Society of Australia; Cancer Society of New Zealand; Clinical Oncology Society of Australia; Haematology Society of Australia and New Zealand; National Centre for Infections in Cancer; New Zealand Cancer Control Agency; New Zealand Society for Oncology; and Palliative Care Australia. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
18. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).
- Author
-
King, Madeleine T., Agar, Meera, Currow, David C., Hardy, Janet, Fazekas, Belinda, and McCaffrey, Nikki
- Subjects
- *
PALLIATIVE treatment , *KARNOFSKY Performance Status , *QUALITY of life , *STATISTICAL reliability , *CANCER pain , *VOMITING treatment , *CHRONIC pain treatment , *TUMOR treatment , *CHRONIC pain , *CLINICAL trials , *SELF-evaluation , *PSYCHOMETRICS , *VOMITING , *QUESTIONNAIRES , *TUMORS , *DISEASE complications ,RESEARCH evaluation - Abstract
Purpose: Head-to-head comparison of reliability, validity and responsiveness of four patient-reported outcome measures (PROMS) suitable for assessing health-related quality of life (HRQOL) in palliative care settings: EORTC QLQ-C15-PAL, FACT-G7, FACIT-Pal and short-form FACIT-Pal-14.Methods: Secondary analysis of two phase III randomised trials: ketamine for chronic cancer pain, octreotide for vomiting in inoperable malignant bowel obstruction. Sub-groups were defined by Australia-modified Karnofsky performance status (AKPS) and participants' global impression of change (GIC). Two aspects of reliability were assessed: internal consistency (Cronbach alpha, α); test-retest reliability (intra-class correlation coefficient (ICC)) of patients with stable AKPS and those who self-reported 'no change' on GIC. Construct validity was assessed via pre-determined hypotheses about sensitivity of PROM scores to AKPS groups and responsiveness of PROM change scores to GIC groups using analysis of variance.Results: FACIT-Pal had better internal consistency (α ranged 0.59-0.80, 15/18 ≥ 0.70) than QLQ-C15-PAL (0.51-0.85, 4/8 ≥ 0.70) and FACT-G7 (0.54-0.64, 0/2 ≥ 0.70). FACIT scales had better test-retest reliability (FACIT-Pal 11/27 ICCs ≥ 0.70, FACT-G7 2/3 ICCs ≥ 0.70) than QLQ-C15-PAL (2/30 ICCs ≥ 0.70, 18/30 ≤ 0.5). Four scales demonstrated sensitivity to AKPS: QLQ-PAL-15 Physical Functioning and Global QOL, FACT-G Functional Wellbeing and FACIT-Pal Trial Outcome Index (TOI). Nine scales demonstrated responsiveness: three in the ketamine trial population (QLQ-C15-PAL Pain, FACIT-Pal-14, FACT-G7), six in the octreotide trial population (QLQ-C15-PAL Fatigue; FACIT-Pal PalCare, TOI, Total; FACT-G Physical Wellbeing and Total).Conclusions: No PROM was clearly superior, confirming that choosing the best PROM requires careful consideration of the research goals, patient population and the domains of HRQOL targeted by the intervention being investigated. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
19. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
- Author
-
Currow, David, Louw, Sandra, McCloud, Philip, Fazekas, Belinda, Plummer, John, McDonald, Christine F., Agar, Meera, Clark, Katherine, McCaffery, Nikki, Ekström, Magnus Pär, Australian National Palliative Care Clinical Studies Collaborative (PaCCSC), and McCaffrey, Nikki
- Subjects
DYSPNEA ,MORPHINE ,CONTROLLED release drugs ,TREATMENT effectiveness ,NARCOTICS ,RESEARCH ,ANALGESICS ,CHRONIC diseases ,ORAL drug administration ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,COMPARATIVE studies ,RANDOMIZED controlled trials ,BLIND experiment ,QUALITY of life ,CONTROLLED release preparations - Abstract
Introduction: Morphine may decrease the intensity of chronic breathlessness but data from a large randomised controlled trial (RCT) are lacking. This first, large, parallel-group trial aimed to test the efficacy and safety of regular, low-dose, sustained-release (SR) morphine compared with placebo for chronic breathlessness.Methods: Multisite (14 inpatient and outpatient cardiorespiratory and palliative care services in Australia), parallel-arm, double-blind RCT. Adults with chronic breathlessness (modified Medical Research Council≥2) were randomised to 20 mg daily oral SR morphine and laxative (intervention) or placebo and placebo laxative (control) for 7 days. Both groups could take ≤6 doses of 2.5 mg, 'as needed', immediate-release morphine (≤15 mg/24 hours) as required by the ethics review board. The primary endpoint was change from baseline in intensity of breathlessness now (0-100 mm visual analogue scale; two times per day diary) between groups. Secondary endpoints included: worst, best and average breathlessness; unpleasantness of breathlessness now, fatigue; quality of life; function; and harms.Results: Analysed by intention-to-treat, 284 participants were randomised to morphine (n=145) or placebo (n=139). There was no difference between arms for the primary endpoint (mean difference -0.15 mm (95% CI -4.59 to 4.29; p=0.95)), nor secondary endpoints. The placebo group used more doses of oral morphine solution during the treatment period (mean 8.7 vs 5.8 doses; p=0.001). The morphine group had more constipation and nausea/vomiting. There were no cases of respiratory depression nor obtundation.Conclusion: No differences were observed between arms for breathlessness, but the intervention arm used less rescue immediate-release morphine.Trial Registration Number: ACTRN12609000806268. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
20. Prevalence and severity of sleep difficulty in patients with a CNS cancer receiving palliative care in Australia.
- Author
-
Jeon, Megan S, Dhillon, Haryana M, Descallar, Joseph, Lam, Lawrence, Allingham, Samuel, Koh, Eng-Siew, Currow, David C, and Agar, Meera R
- Subjects
PALLIATIVE treatment ,SLEEP ,PSYCHOLOGICAL distress ,MULTILEVEL models ,CANCER patients - Abstract
Background The literature describing the incidence of sleep difficulty in CNS cancers is very limited, with exploration of a sleep difficulty symptom trajectory particularly sparse in people with advanced disease. We aimed to establish the prevalence and longitudinal trajectory of sleep difficulty in populations with CNS cancers receiving palliative care nationally, and to identify clinically modifiable predictors of sleep difficulty. Methods A consecutive cohort of 2406 patients with CNS cancers receiving palliative care from sites participating in the Australian national Palliative Care Outcomes Collaboration were evaluated longitudinally on patient-reported sleep difficulty from point-of-care data collection, comorbid symptoms, and clinician-rated problems. Multilevel models were used to analyze patient-reported sleep difficulty. Results Reporting of mild to severe sleep difficulties ranged from 10% to 43%. Sleep scores fluctuated greatly over the course of palliative care. While improvement in patients' clinical status was associated with less sleep difficulty, the relationship was not clear when patients deteriorated. Worsening of sleep difficulty was associated with higher psychological distress (P <.0001), greater breathing problems (P <.05) and pain (P <.05), and higher functional status (P <.001) at the beginning of care. Conclusions Sleep difficulty is prevalent but fluctuates widely in patients with CNS cancers receiving palliative care. A better-tailored sleep symptom assessment may be needed for this patient population. Early interventions targeting psychological distress, breathing symptoms, and pain for more functional patients should be explored to see whether it reduces sleep difficulties late in life. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. "A Real Bucket of Worms": Views of People Living with Dementia and Family Members on Supported Decision-Making.
- Author
-
Sinclair, Craig, Gersbach, Kate, Hogan, Michelle, Blake, Meredith, Bucks, Romola, Auret, Kirsten, Clayton, Josephine, Stewart, Cameron, Field, Sue, Radoslovich, Helen, Agar, Meera, Martini, Angelita, Gresham, Meredith, Williams, Kathy, and Kurrle, Sue
- Subjects
AUTONOMY (Psychology) ,DECISION making ,DEMENTIA ,DEMENTIA patients ,INTERVIEWING ,PHENOMENOLOGY ,THEMATIC analysis ,PATIENTS' attitudes ,FAMILY attitudes - Abstract
Supported decision-making has been promoted at a policy level and within international human rights treaties as a way of ensuring that people with disabilities enjoy the right to legal capacity on an equal basis with others. However, little is known about the practical issues associated with implementing supported decision-making, particularly in the context of dementia. This study aimed to understand the experiences of people with dementia and their family members with respect to decision-making and their views on supported decision-making. Thirty-six interviews (twenty-one dyadic and fifteen individual) were undertaken with fifty-seven participants (twenty-five people living with dementia and thirty-two family members) across three states in Australia. Interpretative Phenomenological Analysis (IPA) was used as the methodological approach, with relational autonomy as a theoretical perspective. We identified two overarching themes relating to participants' experiences with decision-making: "the person in relationship over time" and "maintaining involvement." Participant views on the practical issues associated with supported decision-making are addressed under the themes of "facilitating decision-making," "supported decision-making arrangements," "constraints on decision-making," and "safeguarding decision-making." While participants endorsed the principles of supported decision-making as part of their overarching strategy of "maintaining involvement" in decision-making, they recognized that progressive cognitive impairment meant that there was an inevitable transition toward greater involvement of, and reliance upon, others in decision-making. Social and contextual "constraints on decision-making" also impacted on the ability of people with dementia to maintain involvement. These themes inform our proposal for a "spectrum approach" to decision-making involvement among people living with dementia, along with recommendations for policy and practice to assist in the implementation of supported decision-making within this population. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. Pharmacists' perspectives on medication reviews for long-term care residents with advanced dementia: a qualitative study.
- Author
-
Disalvo, Domenica, Luckett, Tim, Bennett, Alexandra, Davidson, Patricia, and Agar, Meera
- Subjects
MEDICATION reconciliation ,PHARMACISTS ,RESIDENTIAL mobility ,MEDICATION therapy management ,DEMENTIA ,QUALITATIVE research ,TREATMENT of dementia ,ATTITUDE (Psychology) ,HEALTH care teams ,LONG-term health care ,MEDICAL personnel ,PSYCHOSOCIAL factors ,FERRANS & Powers Quality of Life Index - Abstract
Background Medication reviews by pharmacists have been shown to identify and reduce drug-related problems in long-term care residents. Objective To explore pharmacist perspectives of the Australian Government funded pharmacist-conducted residential medication management review and its role improving the quality and safety of prescribing in long-term care, in particular for those living with advanced dementia. Setting Australian Long-term care pharmacists. Method A qualitative research methodology approach using semi-structured interviews was used, with participants pharmacists with Residential Medication Management Review experience. Interviews were recorded, transcribed and coded utilising a meta-model of Physician-Community Pharmacy Collaboration in medication review. Main outcome measure Pharmacists' perspectives on the Residential Medication Management Review and how to improve the quality of reviews for residents with advanced dementia. Results Fifteen accredited pharmacists participated. The majority believed that the Residential Medication Management Review had the potential to improve the quality and safety of medicines but highlighted systemic issues that worked against collaborative practice. Participants emphasised the importance of three-way collaboration between general practitioners, pharmacists and nursing staff and highlighted key strategies for its optimisation. Conclusion Incorporating avenues for greater communication between team members can improve collaboration between health professionals and ultimately the quality of medication reviews. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.
- Author
-
Sopina, Elizaveta, Chenoweth, Lynn, Luckett, Tim, Agar, Meera, Luscombe, Georgina M., Davidson, Patricia M., Pond, Constance D., Phillips, Jane, and Goodall, Stephen
- Subjects
QUALITY of life ,DEMENTIA ,REGRESSION analysis ,MEASURING instruments - Abstract
Background: Assessing health-related quality of life (HRQOL) in people with advanced dementia is challenging but important for informed decision-making. Proxy measurement of this construct is difficult and is often rated lower than self-report. Accurate proxy rating of quality of life in dementia is related to identification of concepts important to the person themselves, as well as the sensitivity of the measures used. The main aim of this study was to compare the performance of two instruments-QUALID and EQ-5D-5L-on measuring HRQOL in people with advanced dementia.Methods: In a sub-study nested within a cluster-RCT we collected proxy(nurse)-completed EQ-5D-5L and QUALID measures at baseline, 3, 6, 9 and 12 months' follow-up for people with advanced dementia, residing in 20 nursing homes across Australia. Spearman's rank correlations, partial correlations and linear regressions were used to assess the relationship between the HRQOL instrument scores and their changes over time.Results: The mean weight from 284 people for the EQ-5D-5L and QUALID at baseline were 0.004 (95% CI - 0.026, 0.033) and 24.98 (95% CI 24.13, 25.82), respectively. At 12 months' follow-up, 115 participants remained alive. EQ-5D-5L weights and QUALID scores at baseline and at follow-up were moderately correlated (r = - 0.437; p < 0.001 at 12 months). Changes within QUALID and EQ-5D-5L across the same follow-up periods were also correlated (r = - 0.266; p = 0.005). The regression analyses support these findings.Conclusion: Whilst these quality of life instruments demonstrated moderate correlation, the EQ-5D-5L does not appear to capture all aspects of quality of life that are relevant to people with advanced dementia and we cannot recommend the use of this instrument for use within this population. The QUALID appears to be a more suitable instrument for measuring HRQOL in people with severe dementia, but is not preference-based, which limits its application in economic evaluations of dementia care. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
24. Potentially Inappropriate Prescribing in Australian Nursing Home Residents with Advanced Dementia: A Substudy of the IDEAL Study.
- Author
-
Disalvo, Domenica, Luckett, Tim, Phillips, Jane, Agar, Meera, Luscombe, Georgina, Bennett, Alexandra, Davidson, Patricia, Chenoweth, Lynnette, Mitchell, Geoffrey, Pond, Dimity, Beattie, Elizabeth, and Goodall, Stephen
- Subjects
CHOLINESTERASE inhibitors ,ANTILIPEMIC agents ,PLATELET aggregation inhibitors ,AUDITING ,CONFIDENCE intervals ,DEMENTIA ,NURSING home patients ,REGRESSION analysis ,RETROSPECTIVE studies ,INAPPROPRIATE prescribing (Medicine) ,ODDS ratio ,THERAPEUTICS - Abstract
Background: Prescribing medications for nursing home residents with advanced dementia should focus on optimizing function and comfort, reducing unnecessary harms and aligning care goals with a palliative approach. Objective: The aim of the study was to estimate the proportion of Australian nursing home residents with advanced dementia receiving potentially inappropriate medications, and identify those most commonly prescribed and factors associated with their use. Design: Data were collected through retrospective audit of medication charts. Setting/Subjects: Two hundred eighteen nursing home residents with advanced dementia from 20 nursing homes participated in a cluster-randomized controlled trial of case conferencing (the IDEAL Study) from June 2013 to December 2014. Measurements: Inappropriate drug use was defined as medications classified as "never appropriate" by the Palliative Excellence in Alzheimer Care Efforts (PEACE) program criteria. Generalized linear mixed models were used to identify variables predicting use of "never" appropriate medications. Results: Over a quarter (n = 65, 30%) of residents received at least one medication classed as "never" appropriate, the most common being lipid-lowering agents (n = 38, 17.4%), antiplatelet agents (n = 18, 8.3%), and acetylcholinesterase inhibitors (n = 16, 7.3%). Residents who had been at the nursing home for ≤10 months (odds ratio [OR] 5.60, 95% confidence interval [CI] 1.74–18.06) and 11–21 months (OR 5.41, 95% CI 1.67–17.75) had significantly greater odds of receiving a never appropriate medication compared with residents who had been at the nursing home for >5 years. Conclusions: Use of potentially inappropriate medications in Australian nursing home residents with advanced dementia is common. A greater understanding of the rationale that underpins prescribing of medications is required. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
25. An economic model of advance care planning in Australia: a cost-effective way to respect patient choice.
- Author
-
Kim-Huong Nguyen, Sellars, Marcus, Agar, Meera, Kurrle, Sue, Kelly, Adele, Comans, Tracy, and Nguyen, Kim-Huong
- Subjects
MEDICAL care ,ECONOMIC models ,DEMENTIA ,PRIMARY care ,TERMINAL care ,MEDICAL care costs ,TREATMENT of dementia ,COST effectiveness ,DECISION making ,PATIENT satisfaction ,RESEARCH evaluation ,RESEARCH funding ,ADVANCE directives (Medical care) ,STATISTICAL models ,ECONOMICS - Abstract
Background: Advance care planning (ACP) is a process of planning for future health and personal care. A person's values and preferences are made known so that they can guide decision making at a future time when that person cannot make or communicate his or her decisions. This is particularly relevant for people with dementia because their ability to make decisions progressively deteriorates over time. This study aims to evaluate the cost-effectiveness of delivering a nationwide ACP program within the Australian primary care setting.Methods: A decision analytic model was developed to identify the costs and outcomes of an ACP program for people aged 65+ years who were at risk of developing dementia. Inputs for the model was sourced and estimated from the literature. The reliability of the results was thoroughly tested in sensitivity analyses.Results: The results showed that, compared to usual care, a nationwide ACP program for people aged 65+ years who were at risk of dementia would be cost-effective. However, the results only hold if ACP completion is higher than 50% and adherence to ACP wishes is above 75%.Conclusions: A nationwide ACP program in the primary care setting is a cost-effective or cost-saving intervention compared to usual care in a population at-risk of developing dementia. Cost savings are generated from providing treatment and care that is consistent with patient preferences, resulting in fewer hospitalisations and less-intensive care at end-of-life. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
26. Evidence-based occupational therapy for people with dementia and their families: What clinical practice guidelines tell us and implications for practice.
- Author
-
Laver, Kate, Cumming, Robert, Dyer, Suzanne, Agar, Meera, Anstey, Kaarin J, Beattie, Elizabeth, Brodaty, Henry, Broe, Tony, Clemson, Lindy, Crotty, Maria, Dietz, Margaret, Draper, Brian, Flicker, Leon, Friel, Meg, Heuzenroeder, Louise, Koch, Susan, Kurrle, Sue, Nay, Rhonda, Pond, Dimity, and Thompson, Jane
- Subjects
CAREGIVERS ,DEMENTIA ,MEDICAL information storage & retrieval systems ,PSYCHOLOGY information storage & retrieval systems ,MEDICAL protocols ,MEDLINE ,OCCUPATIONAL therapy services ,ONLINE information services ,QUALITY of life ,RESEARCH funding ,SYSTEMATIC reviews ,EVIDENCE-based medicine ,ACTIVITIES of daily living - Abstract
Background/aim The first evidence-based Clinical Practice Guidelines and Principles of Care for People with Dementia in Australia have been released. The Guidelines detail a number of important evidence-based recommendations for occupational therapists. The aim of this paper is (1) to provide an overview of Guideline development, and (2) to describe the evidence supporting a recommendation for occupational therapy. Common characteristics of effective occupational therapy programmes for people with dementia are described. Methods Guideline development involved adaptation of existing high-quality guidelines developed overseas and 17 systematic reviews to ensure that the most recent high-quality evidence was included. One of the systematic reviews involved examining the evidence for interventions to promote independence in people with dementia. Specifically, we looked at the evidence for occupational therapy and its effect on activities of daily living, quality of life and carer impact. Results A total of 109 recommendations are included in the Guidelines. Occupational therapy was found to significantly increase independence in activities of daily living and improve quality of life. Effective occupational therapy programmes involve: environmental assessment, problem solving strategies, carer education and interactive carer skills training. Conclusion Occupational therapists working with people with dementia in community settings should ensure that their time is spent on those aspects of intervention that are shown to be effective. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
27. Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial.
- Author
-
McCaffrey, Nikki, Hardy, Janet, Fazekas, Belinda, Agar, Meera, Devilee, Linda, Rowett, Debra, and Currow, David
- Subjects
HOSPITAL care ,SUBCUTANEOUS injections ,ANALGESICS ,CANCER pain ,COST control ,DRUG prescribing ,LENGTH of stay in hospitals ,KETAMINE ,NARCOTICS ,PALLIATIVE treatment ,PHYSICIAN practice patterns ,ECONOMICS - Abstract
Objective. The aim of the present study was to estimate the potential healthcare cost savings associated with reduced prescribing of subcutaneous ketamine for the treatment of chronic cancer pain after publication of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial (RCT), to provide further reasons to modify ketamine prescribing practice in this setting. Methods. Potential cost savings in this setting were estimated from a health system perspective using a 1-year impact model. The model was populated with estimates derived using an epidemiological approach informed by morbidity and prevalence data, the PaCCSC feasibility study, ketamine RCT and national ketamine utilisation survey results, as well as clinical opinion. Results. The total estimated annual hospitalisation costs associated with subcutaneous ketamine prescribing were A$3 899 600 (2605 bed-days). A 17% reduction in ketamine prescribing lowered hospitalisation costs to A$3 236 668 (2162 bed-days), a reduction of A$662 932 (443 bed-days) because of reduced in-patient stays associated with ketamine toxicity and prescribing process. Conclusions. The findings from the modelled impact analysis suggest that dissemination of the PaCCSC ketamine RCT results may have saved the Australian healthcare system approximately A$663 000 in annual hospitalisation costs and freed up 443 in-patient bed-days, although there was high uncertainty within the study. Wider dissemination over time and targeted, local de-adoption strategies could result in further savings. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
28. Patients' and caregivers' perceptions of occupational therapy and adapting to discharge home from an inpatient palliative care setting.
- Author
-
Marston, Celia, Agar, Meera, and Brown, Ted
- Subjects
ADAPTABILITY (Personality) ,PSYCHOLOGICAL adaptation ,CAREGIVERS ,INTERVIEWING ,RESEARCH methodology ,OCCUPATIONAL therapists ,OCCUPATIONAL therapy ,PALLIATIVE treatment ,PATIENTS ,SENSORY perception ,RESEARCH funding ,QUALITATIVE research ,JUDGMENT sampling ,HOME environment ,OCCUPATIONAL roles ,THEMATIC analysis ,DISCHARGE planning - Abstract
Introduction: There is limited research into the role of occupational therapy in discharge planning in palliative care. This study aimed to explore patients' and caregivers' perceptions of occupational therapy in the context of discharge home from an inpatient palliative care setting. Method: Semi-structured interviews were conducted with patients and caregivers following discharge home from inpatient palliative care. Participants were selected using purposive sampling and data was thematically analysed. Results: Five caregivers and three patients were interviewed. Three main themes emerged: (1) shared roles in discharge planning; (2) perceived benefits of occupational therapy; and (3) adapting to discharge home. Patients and caregivers viewed occupational therapy as the practical help needed to achieve discharge. They had difficulty differentiating between professional roles and perceived the discharge process as a shared responsibility between themselves and the clinicians. Adapting to discharge home involved coping with the uncertain and unexpected, where limited understanding of professional roles meant participants did not know who to seek assistance from. Conclusion: Occupational therapy was viewed as the practical help needed for discharge home from a palliative care setting. Clinicians need to take primary responsibility for understanding each other's roles and providing information on who can assist after discharge. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
29. Adaptation of international guidelines on assessment and management of cancer pain for the Australian context.
- Author
-
Lovell, Melanie, Luckett, Tim, Boyle, Frances, Stubbs, John, Phillips, Jane, Davidson, Patricia Mary, Olver, Ian, Dincklage, Jutta, and Agar, Meera
- Subjects
CANCER pain ,EARLY detection of cancer ,PHARMACOLOGY ,PATIENT education ,PALLIATIVE treatment - Abstract
Aim To develop clinical practice guidelines for screening, assessing and managing cancer pain in Australian adults. Methods This three-phase project utilized the ADAPTE approach to adapt international cancer pain guidelines for the Australian setting. A Working Party was established to define scope, screen guidelines for adaptation and develop recommendations to support better cancer pain control through screening, assessment, pharmacological and non-pharmacological management, and patient education. Recommendations with limited evidence were referred to Expert Panels for advice before the draft guidelines were opened for public consultation via the Cancer Council Australia Cancer Guidelines Wiki platform in late 2012. All comments were reviewed by the Working Party and the guidelines were revised accordingly. Results Screening resulted in six international guidelines being included for adaptation - those developed by the Scottish Intercollegiate Guidelines Network (2008), National Health Service Quality Improvement Scotland (2009), National Comprehensive Cancer Network (2012), European Society of Medical Oncology (2011), European Association for Palliative Care (2011, 2012) and National Institute of Clinical Excellence (2012). Guideline adaptation resulted in 55 final recommendations. The guidelines were officially launched in November 2013. Conclusion International guidelines can be efficiently reconfigured for local contexts using the ADAPTE approach. Availability of the guidelines via the Cancer Council Australia Wiki is intended to promote uptake and enable recommendations to be kept up to date. Resources to support implementation will also be made available via the Wiki if found to be effective by a randomized controlled trial commencing in 2015. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. Prescribing for Nausea in Palliative Care: A Cross-Sectional National Survey of Australian Palliative Medicine Doctors.
- Author
-
To, Timothy H.M., Agar, Meera, Yates, Patsy, and Currow, David C.
- Subjects
- *
NAUSEA treatment , *CHI-squared test , *DRUG prescribing , *CASE studies , *NAUSEA , *PALLIATIVE treatment , *PHYSICIANS , *QUESTIONNAIRES , *RESEARCH funding , *PHYSICIAN practice patterns , *CROSS-sectional method , *HALOPERIDOL , *DATA analysis software , *DESCRIPTIVE statistics , *METOCLOPRAMIDE - Abstract
Background: Nausea can be a debilitating symptom for patients with a life-limiting illness. While addressing reversible components, nonpharmacological strategies and antiemetics are the main therapeutic option. The choice of medication, dose, and route of administration remain highly variable. Objective: The aim of this study was to codify the current clinical approaches and quantify any variation found nationally. Methods: A cross-sectional study utilizing a survey of palliative medicine clinicians examined prescribing preferences for nausea using a clinical vignette. Respondent characteristics, the use of nonpharmacological interventions, first- and second-line antiemetic choices, commencing and maximal dose, and time to review were collected. Results: Responding clinicians were predominantly working in palliative medicine across a range of settings with a 49% response rate (105/213). The main nonpharmacological recommendation was 'small, frequent snacks.' Metoclopramide was the predominant first-line agent (69%), followed by haloperidol (26%), while second-line haloperidol was the predominant agent (47%), with wide variation in other nominated agents. Respondents favoring metoclopramide as first-line tended to use haloperidol second-line (65%), but not vice versa. Maximal doses for an individual antiemetic varied up to tenfold. Conclusion: For nausea, a commonly encountered symptom in palliative care, clinicians' favored metoclopramide and haloperidol; however, after these choices, there was large variation in antiemetic selection. While most clinicians recommended modifying meal size and frequency, use of other nonpharmacological therapies was limited. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
31. Australian survey of current practice and guideline use in adult cancer pain assessment and management: Perspectives of oncologists.
- Author
-
Luckett, Tim, Davidson, Patricia Mary, Boyle, Frances, Liauw, Winston, Agar, Meera, Green, Anna, and Lovell, Melanie
- Subjects
CANCER pain treatment ,MEDICAL personnel ,ONCOLOGISTS ,CANCER treatment ,CANCER research ,CANCER patient medical care ,ATTITUDE (Psychology) - Abstract
Aims Cancer pain continues to be undertreated in up to half of cases, despite the availability of evidence-based guidelines. This study aimed to: (i) identify barriers and facilitators to adult cancer pain assessment and management, as perceived by Australian health professionals; (ii) establish the perceived need for new Australian guidelines and implementation strategy; (iii) identify which guidelines are used; (iv) identify barriers and facilitators to guideline use. This article focuses on the perceptions of responding oncologists. Methods A cross-sectional survey was administered online. Invitations were circulated via peak bodies and clinical leaders. Comments were coded independently by two researchers. Results In all 76 oncologists self-reported high concordance with evidence-based recommendations, except validated pain scales. Perceived barriers to pain management included insufficient non-pharmacological interventions, access to /coordination between services, and time. Only 22 percent of respondents reported using pain guidelines. Perceived barriers to guideline use included lack of access, awareness and any single standard. Respondents were generally supportive of new Australian guidelines and especially an implementation strategy. Conclusion Barriers to evidence-based practice and guideline use identified by our survey might be addressed via a clinical pathway that gives step-by-step guidance on evidence-based practice along with a framework for evaluation. Particular attention should be paid to promoting use of validated scales, patient education and non-pharmacological interventions, training of an appropriately skilled workforce and improving care coordination. Challenges are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
32. Australian Survey of Current Practice and Guideline Use in Adult Cancer Pain Assessment and Management: Perspectives of Palliative Care Physicians.
- Author
-
Lovell, Melanie, Agar, Meera, Luckett, Tim, Davidson, Patricia M., Green, Anna, and Clayton, Josephine
- Subjects
- *
CANCER pain treatment , *MEDICAL personnel , *MEDICAL protocols , *PALLIATIVE treatment , *QUESTIONNAIRES , *DISEASE management , *PAIN measurement , *CROSS-sectional method , *PHYSICIANS' attitudes , *DESCRIPTIVE statistics - Abstract
Background: Cancer pain continues to be undertreated, despite the availability of evidence-based guidelines. The Australian National Pain Strategy identified establishment of systems and guidelines to adequately manage cancer pain as a high priority. Objectives: This study aimed to identify barriers and facilitators to adult cancer pain assessment and management as perceived by Australian health professionals; establish the perceived need for new Australian guidelines and implementation strategies; identify which guidelines are used; and identify barriers and facilitators to guideline use. This article focuses on the perceptions of responding palliative care physicians. Design: A cross-sectional survey was administered online. Participants: Invitations were circulated via peak bodies and clinical leaders. Comments were coded independently by two researchers. Results: Ninety-two palliative care physicians responded to the survey; 39% of the national total. The majority reported barriers to pain management, including insufficient access to nonpharmacologic interventions, poor coordination between services, and management challenges posed by comorbidities. Forty-five percent reported using pain guidelines, most commonly the Australian Therapeutic Guidelines-Palliative Care. Respondents were largely supportive of the development of new Australian guidelines and implementation strategies, in particular any offering advice on specific cases of cancer pain (e.g., neuropathic), patient self-management resources, assessment of patient priorities, and disciplinary roles. Conclusion: Barriers to evidence-based practice identified by our survey might be addressed via strategies to support decision making and coordination of care (e.g., a clinical pathway). Particular attention should be paid to promoting access to nonpharmacologic interventions and patient education, and improving referral and care coordination. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
33. Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors.
- Author
-
To, Timothy Hm, Agar, Meera, Shelby-James, Tania, Abernethy, Amy P, Doogue, Matthew, Rowett, Debra, Ko, Danielle, and Currow, David C
- Subjects
- *
CHI-squared test , *DRUG prescribing , *FISHER exact test , *PALLIATIVE treatment , *PHYSICIANS , *QUESTIONNAIRES , *PHYSICIAN practice patterns , *OFF-label use (Drugs) , *CROSS-sectional method , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
The article discusses a study conducted to document off-label use policies (including disclosure and consent) in Australian palliative care units and current practices by palliative care clinicians. The study included survey asking clinicians their most frequent off-label medication/indication dyads and unit policies. It states that dyads were classified into unregistered, off-label and on-label, and for the latter. It is concluded that off-label prescribing is poorly recognized by clinicians.
- Published
- 2013
- Full Text
- View/download PDF
34. The Clinical and Social Dimensions of Prescribing Palliative Home Oxygen for Refractory Dyspnea.
- Author
-
Breaden, Katrina, Phillips, Jane, Agar, Meera, Grbich, Carol, Abernethy, Amy P., and Currow, David C.
- Subjects
TREATMENT of dyspnea ,FOCUS groups ,HOME care services ,MEDICAL care ,MEDICAL cooperation ,NURSES' attitudes ,NURSING specialties ,OXYGEN therapy ,PALLIATIVE treatment ,RESEARCH ,SAFETY ,SOUND recordings ,HOSPICE nurses ,JUDGMENT sampling ,THEMATIC analysis ,DATA analysis software ,DESCRIPTIVE statistics - Abstract
Background: Chronic breathlessness is a significant problem in palliative care and oxygen is often prescribed in an attempt to ameliorate it. Often, this prescription falls outside the current funding guidelines for long-term home oxygen use. The aim of this qualitative study was to understand the factors that most influence Australian specialist palliative care nurses' initiation of home oxygen for their patients. Methods: A series of focus groups were held across three states in Australia in 2011 involving specialist palliative care nurses. The invitation to the nurses was sent by e-mail through their national association. Recorded and transcribed data were coded for themes and subthemes. A summary, which included quotes, was provided to participants to confirm. Results: Fifty-one experienced palliative care nurses participated in seven focus groups held in three capital cities. Two major themes were identified: 1) logistic/health service issues (not reported in this paper as specific to the Australian context) involving the local context of prescribing and, 2) clinical care issues that involved assessing the patient's need for home oxygen and ongoing monitoring concerns. Palliative care nurses involved in initiating or prescribing oxygen often reported using oxygen as a second-line treatment after other interventions had been trialed and these had not provided sufficient symptomatic benefit. Safety issues were a universal concern and a person living alone did not emerge as a specific issue among the nurses interviewed. Conclusion: The role of oxygen is currently seen as a second-line therapy in refractory dyspnea by specialist palliative care nurses. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
35. Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials.
- Author
-
Nikles, Jane, Mitchell, Geoffrey K., Hardy, Janet, Agar, Meera, Senior, Hugh, Carmont, Sue-Ann, Schluter, Philip J., Good, Phillip, Vora, Rohan, and Currow, David
- Subjects
CANCER patients ,PALLIATIVE treatment ,PILOCARPINE ,QUALITY of life ,QUESTIONNAIRES ,RESEARCH funding ,RANDOMIZED controlled trials ,BLIND experiment ,XEROSTOMIA - Abstract
Background: It is estimated that 39,000 Australians die from malignant disease yearly. Of these, 60% to 88% of advanced cancer patients suffer xerostomia, the subjective feeling of mouth dryness. Xerostomia has significant physical, social and psychological consequences which compromise function and quality of life. Pilocarpine is one treatment for xerostomia. Most studies have shown some variation in individual response to pilocarpine, in terms of dose used, and timing and extent of response. We will determine a population estimate of the efficacy of pilocarpine drops (6 mg) three times daily compared to placebo in relieving dry mouth in palliative care (PC) patients. A secondary aim is to assess individual patients' response to pilocarpine and provide reports detailing individual response to patients and their treating clinician. Methods/Design: Aggregated n-of-1 trials (3 cycle, double blind, placebo-controlled crossover trials using standardized measures of effect). Individual trials will identify which patients respond to the medication. To produce a population estimate of a treatment effect, the results of all cycles will be aggregated. Discussion: Managing dry mouth with treatment supported by the best possible evidence will improve functional status of patients, and improve quality of life for patients and carers. Using n-of-1 trials will accelerate the rate of accumulation of high-grade evidence to support clinical therapies used in PC. Trial registration: Australia and New Zealand Clinical Trial Registry Number: 12610000840088. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
36. Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol.
- Author
-
Senior, Hugh E. J., Mitchell, Geoffrey K., Nikles, Jane, Carmont, Sue-Ann, Schluter, Philip J., Currow, David C., Vora, Rohan, Yelland, Michael J., Agar, Meera, Good, Phillip D., and Hardy, Janet R.
- Subjects
CANCER complications ,CONFIDENCE intervals ,FATIGUE (Physiology) ,MEDICAL cooperation ,METHYLPHENIDATE ,RESEARCH ,RESEARCH funding ,RANDOMIZED controlled trials ,BLIND experiment ,DATA analysis software ,DESCRIPTIVE statistics - Abstract
Background: It is estimated that 29% of deaths in Australia are caused by malignant disease each year and can be expected to increase with population ageing. In advanced cancer, the prevalence of fatigue is high at 70-90%, and can be related to the disease and/or the treatment. The negative impact of fatigue on function (physical, mental, social and spiritual) and quality of life is substantial for many palliative patients as well as their families/carers. Method/design: This paper describes the design of single patient trials (n-of-1 s or SPTs) of a psychostimulant, methylphenidate hydrochloride (MPH) (5 mg bd), compared to placebo as a treatment for fatigue, with a population estimate of the benefit by the aggregation of multiple SPTs. Forty patients who have advanced cancer will be enrolled through specialist palliative care services in Australia. Patients will complete up to 3 cycles of treatment. Each cycle is 6 days long and has 3 days treatment and 3 days placebo. The order of treatment and placebo is randomly allocated for each cycle. The primary outcome is a reduction in fatigue severity as measured by the Functional Assessment of Cancer Therapy-fatigue subscale (FACIT-F). Secondary outcomes include adverse events, quality of life, additional fatigue assessments, depression and Australian Karnovsky Performance Scale. Discussion: This study will provide high-level evidence using a novel methodological approach about the effectiveness of psychostimulants for cancer-related fatigue. If effective, the findings will guide clinical practice in reducing this prevalent condition to improve function and quality of life. Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12609000794202. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
37. Designing and conducting randomized controlled trials in palliative care: A summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative.
- Author
-
Shelby-James, Tania M, Hardy, Janet, Agar, Meera, Yates, Patsy, Mitchell, Geoff, Sanderson, Christine, Luckett, Tim, Abernethy, Amy P, and Currow, David C
- Subjects
CLINICAL medicine research ,PALLIATIVE treatment ,PLACEBOS ,RESEARCH ethics ,EVIDENCE-based medicine ,SAMPLE size (Statistics) ,HUMAN research subjects ,PATIENT selection - Abstract
Rigorous clinical research in palliative care is challenging but achievable. Trial participants are likely to have deteriorating performance status, co-morbidities and progressive disease. It is difficult to recruit patients, and attrition unrelated to the intervention being trialled is high. The aim of this paper is to highlight practical considerations from a forum held to discuss these issues by active palliative care clinical researchers.To date, the Australian Palliative Care Clinical Studies Collaborative (PaCCSC) has randomized more than 500 participants across 12 sites in 8 Phase III studies. Insights from the 2010 clinical research forum of the PaCCSC are reported. All active Australian researchers in palliative care were invited to present their current research and address three specific questions: (1) What has worked well? (2) What didn’t work well? and (3) How should the research be done differently next time?Fourteen studies were presented, including six double-blind, randomized, controlled, multi-site trials run by the PaCCSC. Key recommendations are reported, including guidance on design; methodologies; and strategies for maximizing recruitment and retention. These recommendations will help to inform future trial design and conduct in palliative care. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
38. Clinical practice guidelines for dementia in Australia.
- Author
-
Laver, Kate, Cumming, Robert G, Dyer, Suzanne M, Agar, Meera R, Anstey, Kaarin J, Beattie, Elizabeth, Brodaty, Henry, Broe, Tony, Clemson, Lindy, Crotty, Maria, Dietz, Margaret, Draper, Brian M, Flicker, Leon, Friel, Margeret, Heuzenroeder, Louise Mary, Koch, Susan, Kurrle, Susan, Nay, Rhonda, Pond, C Dimity, and Thompson, Jane
- Subjects
ALZHEIMER'S disease diagnosis ,ALZHEIMER'S disease treatment ,COGNITION disorders diagnosis ,DIAGNOSIS of dementia ,TREATMENT of dementia ,COGNITION disorders treatment ,CAREGIVER education ,PSYCHIATRIC drugs ,VASCULAR dementia ,COMBINED modality therapy ,COMMUNICATION ,MEDICAL protocols ,PALLIATIVE treatment ,ACTIVITIES of daily living ,DIAGNOSIS ,THERAPEUTICS - Abstract
About 9% of Australians aged 65 years and over have a diagnosis of dementia. Clinical practice guidelines aim to enhance research translation by synthesising recent evidence for health and aged care professionals. New clinical practice guidelines and principles of care for people with dementia detail the optimal diagnosis and management in community, residential and hospital settings. The guidelines have been approved by the National Health and Medical Research Council. The guidelines emphasise timely diagnosis; living well with dementia and delaying functional decline; managing symptoms through training staff in how to provide person-centred care and using non-pharmacological approaches in the first instance; and training and supporting families and carers to provide care. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
39. Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience.
- Author
-
Martin, Jennifer H., Hill, Courtney, Walsh, Anna, Efron, Daryl, Taylor, Kaitlyn, Kennedy, Michael, Galettis, Rachel, Lightfoot, Paul, Hanson, Julie, Irving, Helen, Agar, Meera, and Lacey, Judith
- Subjects
INSTITUTIONAL review boards ,MEDICAL marijuana ,CLINICAL trials ,CLINICAL drug trials ,PATIENT safety ,DRUG storage ,WEED control - Abstract
With cannabis medicines now obtaining legal status in many international jurisdictions (generally on the authorisation of a medical professional), a rapid increase in consumer demand for access to cannabis as a therapeutic option in the treatment and management of a range of indications is being noted. Despite this accessibility, knowledge on optimal use is lacking. Further drug development and clinical trials at regulatory standards are necessary both if a better understanding of the efficacy of cannabis medicines, optimal product formulation and indication-specific dosing is needed and to ensure the broader quality and safety of cannabis medicines in the clinical setting.To enable this, clinical, academic and public calls for the undertaking of rigorous clinical trials to establish an evidence base for the therapeutic use of cannabis medicines have been made internationally. While this commitment to undertake human studies with cannabis medicines is welcomed, it has highlighted unique challenges, notably in the review stages of ethics and governance. This often results in lengthy delays to approval by Human Research Ethics Committees (herein 'HREC', Australia's nomenclature for Institutional Review Boards) and trial commencement. A principal concern in these cases is that in contrast to clinical trials using other more conventional pharmaceutical products, trials of cannabis medicines in humans often involve the use of an investigational product prior to some (or any) of the preclinical and pharmaceutical safety issues being established. This paucity of data around product safety, potential drug interactions, continuity of supply, shelf life and product storage results in apprehension by HRECs and governance bodies to endorse trials using cannabis medicines.This manuscript draws from the experiences of Australian researchers and staff involved in clinical trials of cannabis medicines to describe some of the common difficulties that may be faced in the HREC approval process. It also presents practical advice aimed to assist researchers, HRECs and governance officers navigate this complex terrain. While the authors' experiences are situated within the Australian setting, many of the barriers described are applicable within the international context and thus, the solutions that have been proposed are typically adaptive for use within other jurisdictions. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
40. Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide.
- Author
-
McCaffrey, Nikki, Asser, Tegan, Fazekas, Belinda, Muircroft, Wendy, Agar, Meera, Clark, Katherine, Eckermann, Simon, Lee, Jessica, Joshi, Rohit, Allcroft, Peter, Sheehan, Caitlin, and Currow, David C.
- Subjects
QUALITY of life ,POSTOPERATIVE nausea & vomiting ,BOWEL obstructions ,CLINICAL trial registries ,SUBCUTANEOUS infusions ,PATIENT reported outcome measures ,PLACEBOS - Abstract
Background: This analysis aims to evaluate health-related quality of life (HrQoL) (primary outcome for this analysis), nausea and vomiting, and pain in patients with inoperable malignant bowel obstruction (IMBO) due to cancer or its treatments randomised to standardised therapies plus octreotide or placebo over a maximum of 72 h in a double-blind clinical trial.Methods: Adults with IMBO and vomiting recruited through 12 services spanning inpatient, consultative and community settings in Australia were randomised to subcutaneous octreotide infusion or saline. HrQoL was measured at baseline and treatment cessation (EORTC QLQ-C15-PAL). Mean within-group paired differences between baseline and post-treatment scores were analysed using Wilcoxon Signed Rank test and between group differences estimated using linear mixed models, adjusted for baseline score, sex, age, time, and study arm.Results: One hundred six of the 112 randomised participants were included in the analysis (n = 52 octreotide, n = 54 placebo); 6 participants were excluded due to major protocol violations. Mean baseline HrQoL scores were low (octreotide 22.1, 95% CI 14.3, 29.9; placebo 31.5, 95% CI 22.3, 40.7). There was no statistically significant within-group improvement in the mean HrQoL scores in the octreotide (p = 0.21) or placebo groups (p = 0.78), although both groups reported reductions in mean nausea and vomiting (octreotide p < 0.01; placebo p = 0.02) and pain scores (octreotide p < 0.01; placebo p = 0.03). Although no statistically significant difference in changes in HrQoL scores between octreotide and placebo were seen, an adequately powered study is required to fully assess any differences in HrQoL scores.Conclusion: The HrQoL of patients with IMBO and vomiting is poor. Further research to formally evaluate the effects of standard therapies for IMBO is therefore warranted.Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12608000211369 (date registered 18/04/2008). [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
41. Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial.
- Author
-
Luckett, Tim, Phillips, Jane, Agar, Meera, Lam, Lawrence, Davidson, Patricia M., McCaffrey, Nicola, Boyle, Frances, Shaw, Tim, Currow, David C., Read, Alison, Hosie, Annmarie, and Lovell, Melanie
- Subjects
CANCER pain treatment ,PALLIATIVE treatment of cancer ,PAIN management ,CANCER patient medical care ,PUBLIC health ,RANDOMIZED controlled trials - Abstract
Background: Pain is a common and distressing symptom in people with cancer, but is under-recognised and under-treated. Australian guidelines for 'Cancer Pain Management in Adults' are available on the Cancer Council Australia Cancer Guideline Wiki. This study aims to evaluate the effectiveness and cost-effectiveness of a suite of guideline implementation strategies for improving pain outcomes in adults with cancer in oncology and palliative care outpatient settings.Methods: The study will use a stepped-wedge cluster randomised controlled design, with oncology and palliative care outpatient services as the clusters. Patients will be eligible if they are adults with cancer and pain presenting to participating services during the study period. During an initial control arm, services will routinely screen patients for average and worst pain over the past 24 h using a 0-10 numerical rating scale (NRS) and have unfettered access to online guidelines. During the intervention arm, staff at each service will be encouraged to use: 1) a patient education booklet and self-management resource; 2) an online spaced learning cancer pain education module for clinicians from different disciplines; and 3) audit and feedback of service performance on key indices of cancer pain screening, assessment and management. Service-based clinical change champions will lead implementation of these strategies. The trial's primary outcome will be the probability that patients initially screened as having moderate-severe (≥5/10 NRS) worst pain experience a clinically important improvement one week later, defined as ≥ 30% reduction. Secondary outcomes will include patient empowerment and quality of life, carer experience, and cost-effectiveness. For the main analysis, linear mixed models will be used, accounting for clustering and the longitudinal design. Eighty-two patients per service at six services (N = 492) will provide > 90% power. A qualitative sub-study and analyses of structural and process factors will explore opportunities for further refinement and tailoring of the intervention.Discussion: This pragmatic trial will inform implementation of guidelines across a range of oncology and palliative care outpatient service contexts. If found effective, the implementation strategies will be made freely available on the Wiki alongside the guidelines.Trial Registration: Registered 23/01/2015 on the Australian New Zealand Clinical Trials Registry ( ACTRN12615000064505 ). [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
42. Bridging the gap between attitudes and action: A qualitative exploration of clinician and exercise professional's perceptions to increase opportunities for exercise counselling and referral in cancer care.
- Author
-
Caperchione, Cristina M., Sharp, Paul, Phillips, Jane L., Agar, Meera, Liauw, Winston, Harris, Carole A., Marin, Elizabeth, McCullough, Susan, and Lilian, Ruth
- Subjects
- *
TUMOR treatment , *COUNSELING , *ATTITUDES of medical personnel , *QUALITATIVE research , *MEDICAL referrals , *EXERCISE , *EXERCISE physiologists - Abstract
Objective: This study aimed to 1) understand factors impacting the implementation of exercise communication and referral, and 2) explore integrated clinical approaches to exercise communication and referral in cancer care.Methods: Seven focus groups (N = 53) were conducted with clinicians and exercise professionals throughout Sydney, Australia. A sub-sample of participants (n = 9) attended a half-day workshop to identifying best practice approaches for moving forward. Data were analysed using thematic content analysis.Results: Two themes emerged: 1) Factors impacting the knowledge-to-action gap, inclusive of limited exercise specific knowledge and training opportunities, funding structure, and current referral process, and 2) Recommendations for a consistent and efficient way forward, detailing the need for oncologist-initiated communication, distribution of cancer-exercise resources, and access to exercise professionals with cancer expertise.Conclusions: This study identified factors (e.g., cancer-exercise specific training, integration of exercise physiologists) influencing exercise counselling and referral. A potential implementation-referral approach accounting for these factors and how to incorporate exercise into a standard model of cancer care, is described. Future testing is required to determine feasibility and practicality of these approaches.Practical Implications: A pragmatic model is provided to guide implementation-referral, inclusive of oncologist-initiated communication exchange, relevant resources, and access to exercise professionals with cancer expertise. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
43. The Palliative Care-Promoting Access and Improvement of the Cancer Experience (PC-PAICE) Project in India: A Multisite International Quality Improvement Collaborative.
- Author
-
Lorenz, Karl A., Mickelsen, Jake, Vallath, Nandini, Bhatnagar, Sushma, Spruyt, Odette, Rabow, Michael, Agar, Meera, Dy, Sydney M., Anderson, Karen, Deodhar, Jayita, Digamurti, Leela, Palat, Gayatri, Rayala, Spandana, Sunilkumar, M.M., Viswanath, Vidya, Warrier, Jyothi Jayan, Gosh-Laskar, Sarbani, Harman, Stephanie M., Giannitrapani, Karleen F., and Satija, Anchal
- Subjects
- *
PALLIATIVE treatment , *PATIENT care , *DIDACTIC method (Teaching method) , *PROJECT method in teaching , *TUMOR treatment , *MEDICAL quality control , *RESEARCH , *RESEARCH methodology , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *QUALITY assurance - Abstract
Mentors at seven U.S. and Australian academic institutions initially partnered with seven leading Indian academic palliative care and cancer centers in 2017 to undertake a program combining remote and in-person mentorship, didactic instruction, and project-based learning in quality improvement (QI). From its inception in 2017 to 2020, the Palliative Care-Promoting Accesst and Improvement of the Cancer Experience Program conducted three cohorts for capacity building of 22 Indian palliative care and cancer programs. Indian leadership established a Mumbai QI training hub in 2019 with philanthropic support. In 2020, the project which is now named Enable Quality, Improve Patient care - India (EQuIP-India) focuses on both palliative care and cancer teams. EQuIP-India now leads ongoing Indian national collaboratives and training in QI and is integrated into India's National Cancer Grid. Palliative Care-Promoting Accesst and Improvement of the Cancer Experience demonstrates a feasible model of international collaboration and capacity building in palliative care and cancer QI. It is one of the several networked and blended learning approaches with potential for rapid scaling of evidence-based practices. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness-A Multisite Randomized Placebo Controlled Trial.
- Author
-
Ferreira, Diana H., Louw, Sandra, McCloud, Philip, Fazekas, Belinda, McDonald, Christine F., Agar, Meera R., Clark, Katherine, McCaffrey, Nikki, Ekström, Magnus, Currow, David C., and Australian National Palliative Care Clinical Studies Collaborative (PaCCSC)
- Subjects
- *
OXYCODONE , *DYSPNEA , *PLACEBOS , *MEDICAL research , *PALLIATIVE treatment , *THERAPEUTIC use of narcotics , *RESEARCH , *ANALGESICS , *RESEARCH methodology , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *RANDOMIZED controlled trials , *QUALITY of life , *CONTROLLED release preparations , *BLIND experiment - Abstract
Context: Chronic breathlessness is a clinical syndrome that results in significant distress and disability. Morphine can reduce chronic breathlessness when the contributing etiologies are optimally treated.Objectives: Does oxycodone reduce chronic breathlessness compared with placebo?Methods: A multisite, randomized, placebo-controlled, double-blind, parallel-arm, fixed-dose trial of oral controlled-release oxycodone 15 mg (5 mg, eight hourly) or placebo (ACTRN12609000806268 at www.anzctr.org.au). As-needed immediate-release morphine (2.5 mg per dose; six and less doses/day) was available for both arms as required by one ethics committee overseeing the trial. Recruitment occurred from 2010 to 2014 in 14 inpatient and outpatient respiratory, cardiology, and palliative care services across Australia. Participants were adults, with chronic breathlessness (modified Medical Research Council Scale 3 or 4), who were opioid naive. The primary end point was the proportion of people with greater than 15% reduction from baseline in the intensity of breathlessness now (0-100 mm visual analogue scale) comparing arms Days 5-7. Secondary end points were average and worst breathlessness, quality of life, function, and harms.Results: Of 157 participants randomized, 155 were included (74 oxycodone and 81 placebo), but the study did not reach target recruitment. There was difference in neither between groups for the primary outcome (P = 0.489) nor any of the prespecified secondary outcomes. Placebo participants used more as-needed morphine (mean 7.0 vs. 4.2 doses; P ≤ 0.001). Oxycodone participants reported more nausea (P < 0.001).Conclusion: There was no signal of benefit from oxycodone over placebo. Future research should focus on investigating the existence of an opioid class effect on the reduction of chronic breathlessness. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
45. Caregivers' Perspectives on the Use of Long-Term Oxygen Therapy for the Treatment of Refractory Breathlessness: A Qualitative Study.
- Author
-
Collier, Aileen, Breaden, Katrina, Phillips, Jane L., Agar, Meera, Litster, Caroline, and Currow, David C.
- Subjects
- *
TREATMENT of dyspnea , *OXYGEN therapy , *PALLIATIVE treatment , *CAREGIVERS , *QUALITATIVE research , *PSYCHOLOGY of caregivers , *PSYCHOLOGICAL stress , *PSYCHOLOGICAL factors - Abstract
Context: Despite limited clinical evidence, long-term oxygen therapy (LTOT) is used for the management of refractory breathlessness in people with life-limiting illnesses who are not necessarily hypoxemic.Objectives: The aim of this study was to understand caregiver factors associated with caring for someone with LTOT from the perspectives and experiences of caregivers themselves.Methods: The qualitative study used semistructured interviews. The study was conducted in two states in Australia. Participants (n = 20) were self-nominated caregivers of people receiving LTOT for refractory breathlessness in the palliative setting.Results: Data analyses established one overarching theme titled: "Oxygen giveth (something to help caregivers relieve breathlessness) and oxygen taketh away (from patients who lose some autonomy)." The theme captured caregivers' feelings of extreme distress in response to witnessing refractory breathlessness, and oxygen fulfilling several critical and beneficial roles in this context. In parallel, caregivers also explicitly and implicitly articulated several downsides to the use of LTOT.Conclusion: Caregivers find caring for someone with refractory breathlessness extremely distressing. The benefits of LTOT are often overestimated, whereas its potential harms are underestimated. As significant stakeholders of people receiving LTOT, caregivers should be provided with opportunities to collaborate with clinicians in evidence-based decision making, efforts should be made to provide them with information and education about the most effective pharmacological and nonpharmacological strategies to manage refractory breathlessness in a palliative care setting including the appropriate use of LTOT to enable them to do so. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
46. Clinicians' Perspectives on Managing Symptom Clusters in Advanced Cancer: A Semistructured Interview Study.
- Author
-
Dong, Skye T., Butow, Phyllis N., Agar, Meera, Lovell, Melanie R., Boyle, Frances, Stockler, Martin, Forster, Benjamin C., and Tong, Allison
- Subjects
- *
CANCER treatment , *ONCOLOGY , *PALLIATIVE treatment , *DISEASE management , *GROUNDED theory , *TUMOR treatment , *ATTITUDE (Psychology) , *COMPARATIVE studies , *INTERVIEWING , *RESEARCH methodology , *MEDICAL cooperation , *MEDICAL personnel , *PSYCHOLOGY of physicians , *RESEARCH , *SYNDROMES , *QUALITATIVE research , *EVALUATION research - Abstract
Context: Managing symptom clusters or multiple concurrent symptoms in patients with advanced cancer remains a clinical challenge. The optimal processes constituting effective management of symptom clusters remain uncertain.Objectives: To describe the attitudes and strategies of clinicians in managing multiple co-occurring symptoms in patients with advanced cancer.Methods: Semistructured interviews were conducted with 48 clinicians (palliative care physicians [n = 10], oncologists [n = 6], general practitioners [n = 6], nurses [n = 12], and allied health providers [n = 14]), purposively recruited from two acute hospitals, two palliative care centers, and four community general practices in Sydney, Australia. Transcripts were analyzed using thematic analysis and adapted grounded theory.Results: Six themes were identified: uncertainty in decision making (inadequacy of scientific evidence, relying on experiential knowledge, and pressure to optimize care); attunement to patient and family (sensitivity to multiple cues, prioritizing individual preferences, addressing psychosocial and physical interactions, and opening Pandora's box); deciphering cause to guide intervention (disaggregating symptoms and interactions, flexibility in assessment, and curtailing investigative intrusiveness); balancing complexities in medical management (trading off side effects, minimizing mismatched goals, and urgency in resolving severe symptoms); fostering hope and empowerment (allaying fear of the unknown, encouraging meaning making, championing patient empowerment, and truth telling); and depending on multidisciplinary expertise (maximizing knowledge exchange, sharing management responsibility, contending with hierarchical tensions, and isolation and discontinuity of care).Conclusion: Management of symptom clusters, as both an art and a science, is currently fraught with uncertainty in decision making. Strengthening multidisciplinary collaboration, continuity of care, more pragmatic planning of clinical trials to address more than one symptom, and training in symptom cluster management are required. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
47. Factors influencing fidelity to guideline implementation strategies for improving pain care at cancer centres: a qualitative sub-study of the Stop Cancer PAIN Trial.
- Author
-
Luckett T, Phillips J, Agar M, Richards L, Reynolds N, Garcia M, Davidson P, Shaw T, Currow D, Boyle F, Lam L, McCaffrey N, and Lovell M
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Australia, Cancer Care Facilities standards, Pain Management methods, Pain Management standards, Practice Guidelines as Topic, Quality Improvement, Cancer Pain therapy, Guideline Adherence, Qualitative Research
- Abstract
Background: The Stop Cancer PAIN Trial was a phase III pragmatic stepped wedge cluster randomised controlled trial which compared effectiveness of screening and guidelines with or without implementation strategies for improving pain in adults with cancer attending six Australian outpatient comprehensive cancer centres (n = 688). A system for pain screening was introduced before observation of a 'control' phase. Implementation strategies introduced in the 'intervention' phase included: (1) audit of adherence to guideline recommendations, with feedback to clinical teams; (2) health professional education via an email-administered 'spaced education' module; and (3) a patient education booklet and self-management resource. Selection of strategies was informed by the Capability, Opportunity and Motivation Behaviour (COM-B) Model (Michie et al., 2011) and evidence for each strategy's stand-alone effectiveness. A consultant physician at each centre supported the intervention as a 'clinical champion'. However, fidelity to the intervention was limited, and the Trial did not demonstrate effectiveness. This paper reports a sub-study of the Trial which aimed to identify factors inhibiting or enabling fidelity to inform future guideline implementation initiatives., Methods: The qualitative sub-study enabled in-depth exploration of factors from the perspectives of personnel at each centre. Clinical champions, clinicians and clinic receptionists were invited to participate in semi-structured interviews. Analysis used a framework method and a largely deductive approach based on the COM-B Model., Results: Twenty-four people participated, including 15 physicians, 8 nurses and 1 clinic receptionist. Coding against the COM-B Model identified 'capability' to be the most influential component, with 'opportunity' and 'motivation' playing largely subsidiary roles. Findings suggest that fidelity could have been improved by: considering the readiness for change of each clinical setting; better articulating the intervention's value proposition; defining clinician roles and responsibilities, addressing perceptions that pain care falls beyond oncology clinicians' scopes of practice; integrating the intervention within existing systems and processes; promoting patient-clinician partnerships; investing in clinical champions among senior nursing and junior medical personnel, supported by medical leaders; and planning for slow incremental change rather than rapid uptake., Conclusions: Future guideline implementation interventions may require a 'meta-implementation' approach based on complex systems theory to successfully integrate multiple strategies., Trial Registration: Registry: Australian New Zealand Clinical Trials Registry; number: ACTRN 12615000064505; data: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspxid=367236&isReview=true ., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
48. Community Preferences for the Care of Older People at the End of Life: How Important is the Disease Context?
- Author
-
Kenny P, Street DJ, Hall J, Agar MR, and Phillips J
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Australia, Aged, 80 and over, Caregivers psychology, Palliative Care organization & administration, Choice Behavior, Surveys and Questionnaires, Terminal Care organization & administration, Dementia, Neoplasms therapy, Neoplasms psychology, Heart Failure therapy, Patient Preference
- Abstract
Background: Population preferences for care at the end of life can inform palliative care policy and direction. Research investigating preferences for care at the end of life has focused predominantly on the context of advanced cancer, with relatively little attention to other life-limiting illnesses that are common causes of death., Objectives: We aimed to investigate preferences for the care of older people at the end of life in three different disease contexts. The purpose was to understand if population preferences for care in the last 3 weeks of life would differ for patients dying from cancer, heart failure or dementia., Methods: Three discrete choice experiments were conducted in Australia with a general population sample using similar methods but different end-of-life disease contexts. Some attributes were common across the three experiments and others differed to accommodate the specific disease context. Each survey was completed by a different panel sample aged ≥45 years (cancer, n = 1548; dementia, n = 1549; heart failure, n = 1003). Analysis was by separate mixed logit models., Results: The most important attributes across all three surveys were costs to the patient and family, patient symptoms and informal carer stress. The probability of choosing an alternative was lowest (0.18-0.29) when any one of these attributes was at the least favourable level, holding other attributes constant across alternatives. The cancer survey explored symptoms more specifically and found patient anxiety with a higher relative importance score than the symptom attribute of pain. Dementia was the only context where most respondents preferred to not have a medical intervention to prolong life; the probability of choosing an alternative with a feeding tube was 0.40 (95% confidence interval 0.36-0.43)., Conclusions: This study suggests a need for affordable services that focus on improving patient and carer well-being irrespective of the location of care, and this message is consistent across different disease contexts, including cancer, heart failure and dementia. It also suggests some different considerations in the context of people dying from dementia where medical intervention to prolong life was less desirable., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
49. Support needs of Australians bereaved during the COVID-19 pandemic: A cross-sectional survey study.
- Author
-
Ivynian SE, Maccallum F, Chang S, Breen LJ, Phillips JL, Agar M, Hosie A, Tieman J, DiGiacomo M, Luckett T, Philip J, Dadich A, Grossman C, Gilmore I, Harlum J, Kinchin I, Glasgow N, and Lobb EA
- Subjects
- Humans, Female, Male, Middle Aged, Cross-Sectional Studies, Australia epidemiology, Adult, Aged, Surveys and Questionnaires, SARS-CoV-2, Mental Health, Australasian People, COVID-19 epidemiology, COVID-19 psychology, Bereavement, Social Support, Pandemics
- Abstract
Background: COVID-19 disrupted access to bereavement support. The objective of this study was to identify the bereavement supports used by Australians during the COVID-19 pandemic, perceived helpfulness of supports used, prevalence and areas of unmet support need, and characteristics of those with unmet support needs., Methods: A convenience sample of bereaved adults completed an online questionnaire (April 2021-April 2022) about their bereavement experiences including support use and perceived helpfulness, unmet support needs and mental health. Multiple logistic regression was conducted to determine sociodemographic correlates of unmet needs. Open-ended responses were examined using content analysis to determine key themes., Results: 1,878 bereaved Australians completed the questionnaire. Participants were mostly women (94.9%) living in major cities (68%) and reported the death of a parent (45%), with an average age of 55.1 years (SD = 12.2). The five most used supports were family and friends, self-help resources, general practitioners, psychologists, and internet/online community groups. Notably, each was nominated as most helpful and most unhelpful by participants. Two-thirds (66%) reported specific unmet support needs. Those with unmet needs scored lower on mental health measures. Correlates of unmet needs included being of younger age, being a spouse or parent to the deceased; reporting more impacts from public health measures, and not reporting family and friends as supports. The most frequent unmet need was for social support after the death and during lockdown., Conclusions: This study demonstrates the complexity of bereavement support needs during a pandemic. Specialised grief therapy needs to be more readily available to the minority of grievers who would benefit from it. A clear recommendation for a bereavement support action plan is to bolster the ability of social networks to provide support in times of loss. The fostering of social support in the wake of bereavement is a major gap that needs to be addressed in practice, policy, and research., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Ivynian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
50. Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study.
- Author
-
Landers A, Brown H, Al Ruheili J, Russell K, McKenzie C, Agar MR, Yenson VM, Clarke K, and Windsor J
- Subjects
- Humans, Cross-Sectional Studies, New Zealand, Female, Male, Middle Aged, Australia, Aged, Surveys and Questionnaires, Adult, Aged, 80 and over, Pancreatic Neoplasms drug therapy, Enzyme Replacement Therapy methods
- Abstract
Purpose: This study investigated pancreatic enzyme replacement therapy (PERT) use in people diagnosed with pancreatic cancer in New Zealand (NZ) and Australia (AU)., Methods: A cross-sectional survey study was conducted using a mixed-media campaign to recruit people with pancreatic cancer and collect information about current PERT use. The questionnaire gathered data on participant demographics, awareness of PERT, prescribing practices and efficacy of enzyme replacement., Results: Over 300 people with pancreatic cancer were recruited, 135 from New Zealand and 199 from Australia. Every region, state and territory was represented except for the West Coast (NZ) and the Northern Territory (AU), the lowest populated areas in both countries. In New Zealand, 60% of participants had heard about PERT, compared to 69.3% in Australia. Dosing regimens were inconsistent in both countries, with 18% and 27% of participants being prescribed PERT considered best practice in New Zealand and Australia, respectively. Before PERT commencement, 70% of participants experienced symptoms of malabsorption, with all symptoms improving after therapy was established. The majority of participants were compliant with their medication., Conclusion: PERT use in pancreatic cancer in New Zealand and Australia was highly variable and not compliant with international guidelines in which PERT is recommended as standard therapy. Enzyme replacement is effective for improving the symptoms of malabsorption in patients with pancreatic cancer. Clinician education may be needed to help improve the use of PERT in people with pancreatic cancer., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.